S. I. Ankier

1.0k total citations
56 papers, 661 citations indexed

About

S. I. Ankier is a scholar working on Pharmacology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, S. I. Ankier has authored 56 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 10 papers in Cognitive Neuroscience and 9 papers in Psychiatry and Mental health. Recurrent topics in S. I. Ankier's work include Treatment of Major Depression (16 papers), Schizophrenia research and treatment (6 papers) and Sleep and related disorders (6 papers). S. I. Ankier is often cited by papers focused on Treatment of Major Depression (16 papers), Schizophrenia research and treatment (6 papers) and Sleep and related disorders (6 papers). S. I. Ankier collaborates with scholars based in United Kingdom, United States and South Africa. S. I. Ankier's co-authors include SJ Warrington, P. K. Bridges, G.B. West, Karen L. Goa, Alison M. Grant, Richard Marshall, Steve Warrington, Jane E. Murphy, Sameer Ather and Michael S. Starr and has published in prestigious journals such as The British Journal of Psychiatry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

S. I. Ankier

52 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. I. Ankier United Kingdom	15	217	137	133	130	111	56	661
O. Tofanetti Italy	14	113 0.5×	146 1.1×	50 0.4×	139 1.1×	73 0.7×	35	749
Melvyn I. Gluckman United States	15	111 0.5×	197 1.4×	89 0.7×	172 1.3×	44 0.4×	30	574
Marshall B. Wallach United States	15	176 0.8×	269 2.0×	83 0.6×	177 1.4×	52 0.5×	27	697
Barbara F. Roth‐Schechter France	15	145 0.7×	149 1.1×	64 0.5×	177 1.4×	161 1.5×	33	821
Da Prada M Switzerland	11	125 0.6×	215 1.6×	56 0.4×	126 1.0×	99 0.9×	19	566
S.‐Å. Eckernäs Sweden	15	211 1.0×	277 2.0×	188 1.4×	203 1.6×	105 0.9×	29	807
Morselli Pl Italy	16	75 0.3×	125 0.9×	78 0.6×	81 0.6×	228 2.1×	45	682
M. L. Rao Germany	17	79 0.4×	141 1.0×	158 1.2×	267 2.1×	167 1.5×	34	866
Toshiaki Kadokawa Japan	15	129 0.6×	220 1.6×	135 1.0×	241 1.9×	54 0.5×	83	780
Irwin H. Slater United States	12	92 0.4×	197 1.4×	92 0.7×	229 1.8×	29 0.3×	23	654

Countries citing papers authored by S. I. Ankier

Since Specialization

Citations

This map shows the geographic impact of S. I. Ankier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. I. Ankier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. I. Ankier more than expected).

Fields of papers citing papers by S. I. Ankier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. I. Ankier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. I. Ankier. The network helps show where S. I. Ankier may publish in the future.

Co-authorship network of co-authors of S. I. Ankier

This figure shows the co-authorship network connecting the top 25 collaborators of S. I. Ankier. A scholar is included among the top collaborators of S. I. Ankier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. I. Ankier. S. I. Ankier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ankier, S. I., et al.. (1993). Influence of hepatic impairment on the pharmacokinetics of single doses of mirtazapine in elderly subjects. British Journal of Clinical Pharmacology. 35(1). 76. 6 indexed citations

Ankier, S. I., Steve Warrington, & J M Sneddon. (1991). A pharmacokinetic and dynamic study of single nightly doses of conventional and controlled release formulations of trazodone.. PubMed. 13(2). 121–7. 10 indexed citations

Laher, M. S., et al.. (1990). ICI 141,292 (epanolol) —pharmacokinetics after single and repeated oral administration in the elderly with moderate renal impairment. European Journal of Clinical Pharmacology. 39(1). 71–74. 1 indexed citations

Debbas, Nadia, S. I. Ankier, & SJ Warrington. (1989). Trazodone Conventional and Controlled-Release Formulations: Pharmacodynamic Effects After Single and Repeated Administration. Current Medical Research and Opinion. 11(8). 501–509. 4 indexed citations

Trafford, J. A. P., et al.. (1989). A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension. Current Medical Research and Opinion. 11(9). 550–556. 5 indexed citations

Ankier, S. I., et al.. (1989). Clinical Assessment and Performance Tasks in Depression: a Comparison of Amitriptyline and Trazodone. The British Journal of Psychiatry. 155(4). 479–482. 14 indexed citations

Ankier, S. I. & SJ Warrington. (1989). A double‐blind placebo‐controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients. Journal of Internal Medicine. 226(6). 453–458. 20 indexed citations

Ankier, S. I. & SJ Warrington. (1989). Research and Development of New Medicines. Journal of International Medical Research. 17(5). 407–416. 3 indexed citations

Bucknall, C., Daniel J. Brooks, P V Curry, et al.. (1988). Mianserin and trazodone for cardiac patients with depression. European Journal of Clinical Pharmacology. 33(6). 565–569. 13 indexed citations

10.

Ankier, S. I., et al.. (1987). Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients. Xenobiotica. 17(8). 1001–1009. 2 indexed citations

11.

Warrington, Steve, S. I. Ankier, & Paul Turner. (1986). Evaluation of Possible Interactions between Ethanol and Trazodone or Amitriptyline. Neuropsychobiology. 15(1). 31–37. 8 indexed citations

12.

Moon, C. A. L., S. I. Ankier, & Gillian R. Hayes. (1985). Early Morning Insomnia and Daytime Anxiety—A Multicentre General Practice Study Comparing Loprazolam and Triazolam. International Journal of Clinical Practice. 39(9). 352–358. 5 indexed citations

13.

Ather, Sameer, et al.. (1985). A Double‐Blind Evaluation of Trazodone in the Treatment of Depression in the Elderly. International Journal of Clinical Practice. 39(5). 192–199. 26 indexed citations

14.

Silverstone, Trevor, et al.. (1984). A Double-Blind Non-Crossover Placebo-Controlled Study between Group Comparison of Trazodone and Amitriptyline on Cardiovascular Function in Major Depressive Disorder. Psychopathology. 17(2). 64–76. 21 indexed citations

15.

Ankier, S. I., et al.. (1984). Trazodone and Mianserin in General Practice. Psychopathology. 17(2). 24–29. 2 indexed citations

16.

Murphy, Jane E. & S. I. Ankier. (1984). A Comparison of the Hypnotic Activity of Loprazolam, Flurazepam and Placebo. International Journal of Clinical Practice. 38(4). 141–148. 3 indexed citations

17.

Kerr, T. A., et al.. (1984). Trazodone. Acta Psychiatrica Scandinavica. 70(6). 573–577. 12 indexed citations

18.

Silverstone, Trevor, et al.. (1984). Electrophysiological and haemodynamic changes with trazodone, amitriptyline and placebo in depressed out-patients. Current Medical Research and Opinion. 9(5). 339–352. 9 indexed citations

19.

Ankier, S. I.. (1971). Disodium Cromoglycate and Inhibition of Passive Cutaneous Anaphylaxis. International Archives of Allergy and Immunology. 41(1). 163–165. 6 indexed citations

20.

Ankier, S. I. & Michael S. Starr. (1967). THE IMPORTANCE OF PLASMA KININS IN THE ANAPHYLACTOID REACTION IN RATS. British Journal of Pharmacology and Chemotherapy. 31(2). 331–339. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact